NCT00828464

Study to Evaluate Safety, Efficacy and Tolerability of Clobetasol Propionate for Chronic Hand Dermatitis

An Open Label Study to Evaluate Safety, Efficacy and Tolerability of Clobetasol Propionate for the Condition of Chronic Hand Dermatitis

• Status: Completed
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 30 (actual)
• Sponsor: Stiefel, a GSK Company · Industry
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

The purpose of the study is to assess the safety, efficacy and tolerability of Clobetasol propionate foam in subjects with chronic dermatitis.

Detailed description

The study is being conducted in order to obtain safety, efficacy and tolerability data for Clobetasol propionate foam in the treatment of chronic dermatitis. The subjects must have mild to moderate disease based on the Investigator's assessment at baseline.

Conditions

• Hand Dermatosis

Interventions

Type	Name	Description
DRUG	clobetasol propionate	Clobetasol propionate. The study product will be applied topically twice a day (morning and evening) for 14 days of treatment.

Timeline

• Start date: 2008-10-01
• Primary completion: 2009-01-01
• Completion: 2009-01-01
• First posted: 2009-01-26
• Last updated: 2012-10-03
• Results posted: 2010-09-28

Locations

1 site across 1 country: United States